- Home
- SSII vs MDXG Comparison
SSII vs MDXG Comparison
Compare SSII & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SSII | MDXG |
|---|---|---|
| Founded | N/A | 2006 |
| Country | India | United States |
| Employees | 483 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 750.5M | 625.6M |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | SSII | MDXG |
|---|---|---|
| Price | $3.69 | $4.14 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 75.6K | ★ 1.5M |
| Earning Date | 05-14-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $418,630,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $13.02 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.99 |
| 52 Week Low | $3.11 | $3.03 |
| 52 Week High | $10.00 | $7.97 |
Technical Indicators
Market Signals| Indicator | SSII | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 47.77 | 51.41 |
| Support Level | $3.30 | $4.09 |
| Resistance Level | $4.21 | $4.45 |
| Average True Range (ATR) | 0.32 | 0.20 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 41.97 | 56.55 |
Price Performance
Historical ComparisonAbout SSII SS Innovations International Inc.
SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.